In pivot to buzzy ADCs, London biotech Myricx raises $114M with Lilly’s support

On the verge of raising its Series A in late 2021, Myricx Bio faced a tough choice.

The toxicity profile for its IV and oral …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Wysa’s AI-Powered Mental Health Platform Now Available at FQHC

What You Should Know: – Wysa, an AI-guided mental health platform, has partnered with MyCHN, a Federally Qualified Health Center (FQHC) with 14 locations throughout

November 13, 2023

Many patients with Lynch syndrome remain undiagnosed, study finds

New research from Cedars-Sinai Cancer investigators could warrant reconsideration of current screening guidelines to include a poorly recognized cause of Lynch syndrome, the most common

July 12, 2023

Meta Title: “Synlogic Inc Patent: Genetically Engineered Bacteria for Treating Phenylketonuria

Share this article According to GlobalData’s company profile on Synlogic, Peptide pharmacophores was a key innovation area identified from patents. Synlogic‘s grant share as of

March 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.